CN103122394A - 单纯疱疹病毒2型hsv2检测试剂盒 - Google Patents
单纯疱疹病毒2型hsv2检测试剂盒 Download PDFInfo
- Publication number
- CN103122394A CN103122394A CN201310009054XA CN201310009054A CN103122394A CN 103122394 A CN103122394 A CN 103122394A CN 201310009054X A CN201310009054X A CN 201310009054XA CN 201310009054 A CN201310009054 A CN 201310009054A CN 103122394 A CN103122394 A CN 103122394A
- Authority
- CN
- China
- Prior art keywords
- target polynucleotide
- hsv2
- pcr reaction
- reaction solution
- probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000701074 Human alphaherpesvirus 2 Species 0.000 title claims abstract description 50
- 238000001514 detection method Methods 0.000 title claims abstract description 44
- 239000000523 sample Substances 0.000 claims abstract description 63
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 33
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 33
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 33
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 29
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 29
- 239000002157 polynucleotide Substances 0.000 claims abstract description 29
- 230000003321 amplification Effects 0.000 claims abstract description 25
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 9
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 claims abstract description 7
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 claims abstract description 7
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 claims abstract description 7
- 238000012360 testing method Methods 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 31
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 238000011144 upstream manufacturing Methods 0.000 claims description 19
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 16
- 239000012925 reference material Substances 0.000 claims description 16
- 239000013642 negative control Substances 0.000 claims description 7
- 239000013641 positive control Substances 0.000 claims description 7
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 claims description 7
- 102100037111 Uracil-DNA glycosylase Human genes 0.000 claims description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 4
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims description 4
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 claims description 4
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 claims description 4
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 210000004392 genitalia Anatomy 0.000 abstract description 4
- 230000028327 secretion Effects 0.000 abstract description 3
- 238000003752 polymerase chain reaction Methods 0.000 abstract 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
- 235000011164 potassium chloride Nutrition 0.000 abstract 1
- 239000001103 potassium chloride Substances 0.000 abstract 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 abstract 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 description 24
- 239000000243 solution Substances 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000003753 real-time PCR Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000001917 fluorescence detection Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000000171 quenching effect Effects 0.000 description 4
- 208000001688 Herpes Genitalis Diseases 0.000 description 3
- 208000009889 Herpes Simplex Diseases 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 201000004946 genital herpes Diseases 0.000 description 3
- 238000000703 high-speed centrifugation Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 239000011535 reaction buffer Substances 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 239000003398 denaturant Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000700587 Alphaherpesvirinae Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000000903 Herpes simplex encephalitis Diseases 0.000 description 1
- 208000005100 Herpetic Keratitis Diseases 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 206010061308 Neonatal infection Diseases 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 241000202921 Ureaplasma urealyticum Species 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 241000625014 Vir Species 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 239000005549 deoxyribonucleoside Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000010884 herpes simplex virus keratitis Diseases 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000009329 sexual behaviour Effects 0.000 description 1
- 238000012306 spectroscopic technique Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310009054.XA CN103122394B (zh) | 2013-01-10 | 2013-01-10 | 单纯疱疹病毒2型hsv2检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310009054.XA CN103122394B (zh) | 2013-01-10 | 2013-01-10 | 单纯疱疹病毒2型hsv2检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103122394A true CN103122394A (zh) | 2013-05-29 |
CN103122394B CN103122394B (zh) | 2015-04-08 |
Family
ID=48453535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310009054.XA Active CN103122394B (zh) | 2013-01-10 | 2013-01-10 | 单纯疱疹病毒2型hsv2检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103122394B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109852728A (zh) * | 2019-03-13 | 2019-06-07 | 湖北朗德医疗科技有限公司 | 一种检测单纯疱疹病毒-2(hsv-2)的rca方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004097029A2 (en) * | 2003-04-25 | 2004-11-11 | Becton, Dickinson And Company | Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification |
CN101701267A (zh) * | 2009-11-26 | 2010-05-05 | 戴立忠 | 乙型肝炎病毒荧光定量pcr检测试剂盒及其应用 |
CN101979666A (zh) * | 2010-11-05 | 2011-02-23 | 武汉百泰基因工程有限公司 | 快速检测单纯疱疹病毒ⅱ型的荧光定量pcr试剂盒 |
CN102102131A (zh) * | 2009-12-17 | 2011-06-22 | 上海裕隆临床检验中心有限公司 | 检测单纯疱疹病毒ⅱ型荧光pcr试剂盒 |
CN102174660A (zh) * | 2011-02-25 | 2011-09-07 | 湖南圣湘生物科技有限公司 | 乙型肝炎病毒荧光定量pcr检测试剂盒 |
CN102337354A (zh) * | 2011-09-19 | 2012-02-01 | 泰普生物科学(中国)有限公司 | 一种疱疹病毒ⅱ型pcr荧光定量快速检测试剂盒及方法 |
-
2013
- 2013-01-10 CN CN201310009054.XA patent/CN103122394B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004097029A2 (en) * | 2003-04-25 | 2004-11-11 | Becton, Dickinson And Company | Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification |
CN101701267A (zh) * | 2009-11-26 | 2010-05-05 | 戴立忠 | 乙型肝炎病毒荧光定量pcr检测试剂盒及其应用 |
CN102102131A (zh) * | 2009-12-17 | 2011-06-22 | 上海裕隆临床检验中心有限公司 | 检测单纯疱疹病毒ⅱ型荧光pcr试剂盒 |
CN101979666A (zh) * | 2010-11-05 | 2011-02-23 | 武汉百泰基因工程有限公司 | 快速检测单纯疱疹病毒ⅱ型的荧光定量pcr试剂盒 |
CN102174660A (zh) * | 2011-02-25 | 2011-09-07 | 湖南圣湘生物科技有限公司 | 乙型肝炎病毒荧光定量pcr检测试剂盒 |
CN102337354A (zh) * | 2011-09-19 | 2012-02-01 | 泰普生物科学(中国)有限公司 | 一种疱疹病毒ⅱ型pcr荧光定量快速检测试剂盒及方法 |
Non-Patent Citations (1)
Title |
---|
赵友云等: "实时荧光定量PCR鉴别检测单纯疱疹病毒方法的建立", 《武汉大学学报(医学版)》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109852728A (zh) * | 2019-03-13 | 2019-06-07 | 湖北朗德医疗科技有限公司 | 一种检测单纯疱疹病毒-2(hsv-2)的rca方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103122394B (zh) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101701267B (zh) | 乙型肝炎病毒荧光定量pcr检测试剂盒及其应用 | |
CN103509877B (zh) | 一种用于检测prv的荧光定量pcr试剂盒及其应用 | |
CN103060451B (zh) | 一种肺炎支原体mp检测试剂盒 | |
CN103484565B (zh) | 一种实时荧光rt-pcr检测冠状病毒的试剂盒及其应用 | |
CN103060452B (zh) | 沙眼衣原体ct检测试剂盒 | |
CN103060473B (zh) | 一种疱疹类病毒ebv检测试剂盒 | |
CN101979667B (zh) | 同步检测单纯疱疹病毒i型和ⅱ型的荧光定量pcr试剂盒 | |
CN104017907B (zh) | 一种hpv高危型荧光pcr检测试剂盒 | |
CN103725800B (zh) | 一种人腺病毒检测试剂盒 | |
CN103740832A (zh) | 一种新型隐球菌检测试剂盒 | |
CN105624329A (zh) | 单纯疱疹病毒1型实时荧光核酸恒温扩增检测试剂盒 | |
CN105385786B (zh) | 一种人***瘤病毒荧光定量pcr检测试剂盒及其使用方法 | |
CN108060268A (zh) | Hpv分型检测用的引物和探针、试剂盒及试剂盒的使用方法 | |
CN103122396A (zh) | 一种人巨细胞病毒hcmv检测试剂盒 | |
CN104017906B (zh) | 一种hpv高危型分型荧光pcr检测试剂盒 | |
CN102559930A (zh) | 一种荧光定量rt-pcr检测丙型肝炎病毒的试剂盒 | |
CN103074429B (zh) | ***uu检测试剂盒 | |
CN103060453A (zh) | ***ng检测试剂盒 | |
CN105349661A (zh) | 一种沙眼衣原体/***核酸检测试剂盒 | |
CN109487014B (zh) | 单纯疱疹病毒ii型检测标志物、引物探针对、试剂盒及检测方法 | |
CN103173565A (zh) | 低危型人***瘤病毒hpv6/11检测试剂盒 | |
CN103122394B (zh) | 单纯疱疹病毒2型hsv2检测试剂盒 | |
CN104120195B (zh) | 单管辨别优生优育检查中四种病原体的pcr方法及试剂盒 | |
CN103122395A (zh) | 高危型人***瘤病毒hpv16/18检测试剂盒 | |
CN102071261A (zh) | 一种单纯疱疹病毒核酸检测方法及试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HUNAN SHENGWEIER MEDICAL INSPECTION CO., LTD. Free format text: FORMER OWNER: HUNAN SHENGXIANG BIOLOGICAL TECHNOLOGY CO., LTD. Effective date: 20141120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20141120 Address after: 410012, No. 680, Lu Song Road, Changsha hi tech Development Zone, Hunan Applicant after: Hunan company limited of Sheng Weier medical test institute Address before: 410012 No. 198 west slope, Tongzi hi tech Industrial Development Zone, Hunan, Changsha Applicant before: Sansure Biotech Inc. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HUNAN SHENGXIANG BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HUNAN SHENGWEIER MEDICAL INSPECTION CO., LTD. Effective date: 20150526 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150526 Address after: 410012, No. 680, Lu Song Road, hi tech Development Zone, Hunan, Changsha Patentee after: Sansure Biotech Inc. Address before: 410012, No. 680, Lu Song Road, Changsha hi tech Development Zone, Hunan Patentee before: Hunan company limited of Sheng Weier medical test institute |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Herpes simplex virus 2 (HSV-2) detection kit Effective date of registration: 20170711 Granted publication date: 20150408 Pledgee: Ningbo free trade zone Terry with equity investment partnership (limited partnership)|Suzhou equity equity investment center (limited partnership)|Ningbo Meishan Bonded Port District, Jun and equity investment partnership (limited partnership)|Chen Bang Pledgor: Hunan Gene Technology Co.|Hunan San Xiang Biological Technology Co. Ltd. Registration number: 2017430000042 |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 410205 Changsha province high and New Technology Industrial Development Zone, Lu Pine Road, No. 680, Hunan Patentee after: Shengxiang Biotechnology Co., Ltd Address before: 410012, No. 680, Lu Song Road, hi tech Development Zone, Hunan, Changsha Patentee before: Sansure Biotech Inc. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200217 Granted publication date: 20150408 Pledgee: Suzhou Lirui equity investment center (limited partnership)|Triton equity investment partnership (limited partnership)|JUNHE Tongrui equity investment partnership (limited partnership)|Chenbang Pledgor: SANSURE BIOTECH Inc. Registration number: 2017430000042 |
|
TR01 | Transfer of patent right |
Effective date of registration: 20220217 Address after: 410205 No. 680, lushong Road, high tech Development Zone, Changsha, Hunan Patentee after: HUNAN SHENGWEIER MEDICAL INSPECTION Co.,Ltd. Address before: No. 680, lushong Road, high tech Industrial Development Zone, Changsha City, Hunan Province, 410205 Patentee before: Shengxiang Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |